ryanodine and 3-5-dihydroxyphenylglycine

Spinocerebellar ataxia type 2 (SCA2) is an autosomal dominantly inherited, neurodegenerative disease caused by an expansion of polyglutamine tracts in the cytosolic protein ataxin-2 (Atx2). Cerebellar Purkinje cells (PCs) are predominantly affected in SCA2. The cause of PC degeneration in SCA2 is unknown. Here we demonstrate that mutant Atx2-58Q, but not wild-type (WT) Atx2-22Q, specifically associates with the cytosolic C-terminal region of type 1 inositol 1,4,5-trisphosphate receptor (InsP(3)R1), an intracellular calcium (Ca(2+)) release channel. Association with Atx2-58Q increased the sensitivity of InsP(3)R1 to activation by InsP(3) in planar lipid bilayer reconstitution experiments. To validate physiological significance of these findings, we performed a series of experiments with an SCA2-58Q transgenic mouse model that expresses human full-length Atx2-58Q protein under the control of a PC-specific promoter. In Ca(2+) imaging experiments, we demonstrated that stimulation with 3,5-dihydroxyphenylglycine (DHPG) resulted in higher Ca(2+) responses in 58Q PC cultures than in WT PC cultures. DHPG-induced Ca(2+) responses in 58Q PC cultures were blocked by the addition of ryanodine, an inhibitor of the ryanodine receptor (RyanR). We further demonstrated that application of glutamate induced more pronounced cell death in 58Q PC cultures than in WT PC cultures. Glutamate-induced cell death of 58Q PC cultures was attenuated by dantrolene, a clinically relevant RyanR inhibitor and Ca(2+) stabilizer. In whole animal experiments, we demonstrated that long-term feeding of SCA1-58Q mice with dantrolene alleviated age-dependent motor deficits (quantified in beam-walk and rotarod assays) and reduced PC loss observed in untreated SCA2-58Q mice by 12 months of age (quantified by stereology). Results of our studies indicate that disturbed neuronal Ca(2+) signaling may play an important role in SCA2 pathology and also suggest that the RyanR constitutes a potential therapeutic target for treatment of SCA2 patients.

Topics: Animals; Ataxins; Calcium; Calcium Channel Blockers; Calcium Signaling; Cell Death; Cells, Cultured; Chlorocebus aethiops; COS Cells; Dantrolene; Excitatory Amino Acid Agents; Glutamic Acid; Glycine; Inositol 1,4,5-Trisphosphate Receptors; Mice; Mice, Transgenic; Motor Activity; Nerve Degeneration; Nerve Tissue Proteins; Purkinje Cells; Resorcinols; Ryanodine; Spinocerebellar Ataxias

Presynaptic metabotropic glutamate receptors (mGluRs) modulate the release of transmitter from most central synapses. However, difficulties in recording from presynaptic structures has lead to an incomplete understanding of the mechanisms underlying these fundamental processes. By recording directly from presynaptic reticulospinal axons and postsynaptic motoneurons of the lamprey spinal cord, we have obtained electrophysiological and optical evidence that vertebrate presynaptic metabotropic glutamate receptors modulate neurotransmitter release at this synapse through two distinct mechanisms: (1) mGluR activation in the presynaptic terminal depresses transmitter release by activating a presynaptic K+ current, and (2) mGluR activation enhances transmitter release by amplifying the action potential-evoked presynaptic Ca2+ signal by rapidly releasing Ca2+ from intracellular stores in a Ca2+-dependent manner. Furthermore, this effect is mediated by physiological release of glutamate from the presynaptic terminals. These autoreceptor-mediated processes are likely to generate complex effects on transmitter release evoked by repetitive stimulation.

Topics: 4-Aminopyridine; Animals; Calcium; Cycloleucine; Electrophysiology; Excitatory Amino Acid Antagonists; Glycine; Lampreys; Membrane Potentials; Motor Neurons; Neuroprotective Agents; Neurotransmitter Agents; Potassium; Presynaptic Terminals; Receptors, Metabotropic Glutamate; Resorcinols; Ryanodine; Spinal Cord; Synaptic Transmission